The North America patient temperature monitoring market is expected to reach US$ 2,021.51 million by 2027 from US$ 1,331.42 million in 2019; it is estimated to grow at a CAGR of 5.5% from 2020 to 2027.
The key factors driving the growth of patient temperature monitoring are growing prevalence of infectious and chronic diseases and growing awareness of continuous temperature monitoring and preventive care in the region. However, risks associated with the invasive temperature monitoring is the major factor hindering the market growth in North America.Patient temperature monitoring deals with the keeping an eye on temperature variations in the patients. Rise in temperature in commonly observed indication during viral infection or any other critical health related condition. Hence, it is an important aspect for disease diagnosis. There are several products available in the market as per requirement. With the advent of technological advancements, the temperature monitoring is gradually shifting towards remote patient temperature monitoring.
Variation in patient body temperature is a reaction to disease-specific stimuli. Human body regulates its normal temperature to support the body’s own defence mechanism. Additionally, other clinical indications of temperature monitoring such as hypothermia or hyperthermia, infection existence, and analysis of antimicrobial treatments represent significant importance of continuous temperature monitoring. These benefits are expected to accelerate the adoption of thermometers during the forecast period.
Majority of the population in developed and developing countries is undergoing rapid shift from conventional care to preventive care. Healthcare institutions and people are implementing the concept of preventive care and holistic wellness approach to treat health-related conditions. This novel concept of preventive care includes planned doctor visits, immunizations, medications, and screenings. Continuous patient temperature monitoring is one of the important aspects in preventive care. Further, government authorities focus on implementing these preventive measures to prevent or minimize the occurrence of disease. For instance, the Centers of Disease Control and Prevention recommends that all business units should screen the employees’ temperature on daily basis. Such rising emphasis on preventive care and continuous temperature monitoring are extensively projected to drive the North America Patient Temperature Monitoring market growth during the forecast period.
Research institutes, pharmaceutical, and biotech companies are engaged in collaborative work to address the COVID-19 outbreak. The COVID-19 crisis in the region has led to increased adoption of temperature monitoring devices, as it is one of the major factor in diagnosis of COVID-19 infection. Moreover, significant number of players also launched new devices and platform to keep track of patient’s health on the basis of body temperature with increasing incidence of COVID-19 and keep track of patient’s health are certainly projected to have positive impact of adoption of patient temperature monitoring.
Mexico Patient Temperature Monitoring Market, Revenue And Forecast To 2027 (Us$ Mn)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA PATIENT TEMPERATURE MONITORING MARKET SEGMENTATION
By Product
- Handheld Temperature Monitoring Devices
- Table-Top Temperature Monitoring Devices
- Invasive Temperature Monitoring Devices
- Smart Temperature Monitoring Patches
- Wearable Continuous Monitoring Sensors
By Site
- Noninvasive Temperature Monitoring
- Invasive Temperature Monitoring
By Application
- Pyrexia/Fever
- Anesthesia
- Blood Transfusion
- Hypothermia
- Other Applications
By Country
- US
- Canada
- Mexico
Company Profiles
- 3M
- American Diagnostic Corporation
- Cardinal Health Inc
- Biofourmis Inc,
- Fairhaven Health, LLC
- Cycle Technologies
North America Patient Temperature Monitoring Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 1,331.42 Million |
Market Size by 2027 | US$ 2,021.51 Million |
Global CAGR (2020 - 2027) | 5.5% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Product, Site, Application , and Country

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
US, Canada
Trends and growth analysis reports related to Life Sciences : READ MORE..
- 3M
- American Diagnostic Corporation
- Cardinal Health Inc
- Biofourmis Inc,
- Fairhaven Health, LLC
- Cycle Technologies